share

4'',6-Di-o-Methylerythromycin CAS NO 123967-58-8


Unit Price:

CAS No.:123967-58-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

4'',6-Di-o-Methylerythromycin CAS NO 123967-58-8 is a chemically modified derivative of the macrolide antibiotic erythromycin, specifically methylated at the 4'' and 6 hydroxyl positions of the cladinose sugar. This semi-synthetic modification is crucial for enhancing the compound's stability and altering its biological activity profile, making it a valuable intermediate in advanced pharmaceutical research and development. It is primarily utilized by R&D scientists and manufacturers in the pharmaceutical industry for the synthesis of next-generation antibiotics and for probing structure-activity relationships.

Application

  • Pharmaceutical Intermediate: Key starting material or intermediate in the synthesis of novel, potent macrolide antibiotic derivatives.
  • Antibacterial Research: Used in microbiological and pharmacological studies to investigate the impact of specific sugar moiety modifications on antibiotic potency and spectrum.
  • Medicinal Chemistry: A critical building block for creating chemical libraries aimed at overcoming bacterial resistance mechanisms.
  • API Development: Serves as a precursor in the development of Active Pharmaceutical Ingredients (APIs) with improved pharmacokinetic properties.
  • Biochemical Tool: Employed as a standard or probe in studies of bacterial ribosome binding and inhibition.

Basic Information

Product Name 4'',6-Di-o-Methylerythromycin
CAS No. 123967-58-8
Molecular Formula C39H71NO14
Molecular Weight 777.98 g/mol
Synonyms 4'',6-Di-O-methylerythromycin; 4'',6-Di-O-methylerythromycin A; Erythromycin 4'',6-dimethyl ether; 6-O-Methyl-4''-O-methylerythromycin; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
EINECS Contact for details

Quality Control

Our 4'',6-Di-o-Methylerythromycin is produced under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting high standards for research and pharmaceutical use. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 95.0%
Water Content (KF) ≤ 5.0%
Related Substances (HPLC) Total impurities ≤ 3.0% Any single impurity ≤ 1.0%
Residual Solvents (GC) Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.